SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure as traders react to the boards investigation into Jensen Huangs admitted affair with a businesswoman reported to have suspected ties to Chinese intelligence, raising concerns about governance, possible information leaks, and Huangs future as CEO. The community is divided between seeing the probe and leadership uncertainty as a serious overhang and treating the controversy as unrelated to Nvidias AI-chip business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is under heavy selling pressure ahead of its Q3 earnings report, with traders speculating about a possible leak while others see the decline as pre-report positioning; a leak is unconfirmed. Bulls point to growth and potential upbeat guidance, while bears worry that the Eli Lilly obesity-drug deal could pressure margins and profitability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy, focused on the amended upper-limb-function evidence from HOPE-3, is driving attention ahead of the Nov. 22 PDUFA date. Bulls cite the trial data and a letter urging approval from 28 investigators, while skeptics point to FDA scrutiny and the earlier negative advisory-panel vote on the cardiac indication; short-squeeze speculation adds to the debate.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing attention after Oppenheimer upgraded the stock, while Google Clouds use of EPYC processors in its AI infrastructure added a company-specific catalyst. Traders also point to money rotating from Nvidia amid a CEO-related investigation, though some see the move as sentiment-driven and question AMDs valuation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are rallying sharply ahead of its Q3 earnings report, with traders speculating about short covering and an earnings leak, though neither explanation is confirmed. The move has fueled hopes for a turnaround, while many investors worry that weak results or guidance could erase the gains.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Post-merger selling in Agility Robotics is drawing attention, with traders pointing to typical de-SPAC volatility and questioning the companys steep losses, limited revenue, and path to commercial scale. Some remain bullish on humanoid robotics and the companys reported orders, but the discussion is dominated by skepticism about valuation and near-term execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3 Quantum Computing Stocks in the Limelight After October Deals

IonQ, Xanadu and D-Wave gain attention as October deals, manufacturing partnerships and product initiatives offer fresh catalysts for quantum commercialization.

Why Quantum Computing Stock Xanadu Quantum Technologies Plummeted 56.2% in September

Key PointsXanadu completed a business combination with Crane Harbor Acquisition Corp. in March 2026...

Xanadu Stock Rises After Bluefors Deal, Fresh RBC Capital Coverage

Xanadu Quantum Technologies shares are trading higher after announcing a partnership with Bluefors and an RBC Capital coverage initiation.read more...

Xanadu Trending as Investors Digest Lockup Expiration, CEO's Share Sale

Xanadu Quantum Technologies is trending Friday after a post lockup selloff earlier this week, amplified by a disclosed stock sale by CEO.read more...

What's Going On With Xanadu Stock Wednesday?

Xanadu Quantum Technologies shares are rising Wednesday as the stock rebounds from a Tuesday sell-off after its post-merger lockup expired.read more...

Xanadu Stock Hits New Lows: What's Happening?

Xanadu Quantum Technologies Ltd (NASDAQ:XNDU) shares are tumbling Tuesday. The company's standard 180-day post-IPO lockup period expires today. Here's what you need to know.read more...

XNDU Stock Rises On ASML Deal To Fix Photonic Quantum Chips' Optical Loss Problem

Equity

According to CEO Christian Weedbrook, it is the “most important” technical challenge for Xanadu’s photon-based quantum computing architecture.

Why Xanadu Quantum Technologies Stock Slipped 10% This Week

Key PointsXanadu Quantum shareholders are selling, along with the company's common stock offering, which is driving down the stock...

Xanadu sets new industry benchmark in photonic chip packaging

Xanadu sets new industry benchmark in photonic chip packaging Xanadu sets new industry benchmark in photonic chip packaging PR Newswire TORONTO, June 10, 2026 TORONTO, June 10, 2026 /PRNewswire/ - Xanadu Quantum Technologies Limited ("Xanadu") (Nasdaq: XNDU) (TSX: XNDU) today announced a new...

Jim Cramer Says This Quantum Stock 'Makes No Money,' Prefers IBM  And Tells A Crypto Stock's Investors: 'If You Want To Own Bitcoin, Own Bitcoin'

On CNBC's "Mad Money Lightning Round," Jim Cramer said Xanadu Quantum Technologies Limited (NASDAQ:read more...

This account has been verified as an official XNDU representative.

Verified Account

Xanadu

Founded in 2016, Xanadu Quantum Technologies Limited is a Canadian photonic quantum computing company building room-temperature, fault-tolerant quantum computers using light. Xanadu develops hardware and software, including the open-source platform PennyLane. Xanadu is the first pure-play photonic quantum computing company to list on public markets and is recognized globally for its breakthroughs in scalable quantum technologies.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Bearish Sentiment

<ul class="summary-bullets"><li>The companies will explore ways to improve patterning control and reduce optical loss.</li><li>Xanadu has also partnered with EV Group and Mitsubishi Chemical in its push to scale photonic quantum computing.</li><li>Xanadu is targeting more than 1,000 logical qubits by 2031 as it works toward fault-tolerant quantum computing.</li></ul>Xanadu Quantum Technologies (XNDU) shares gained in early morning trade on Wednesday after the company announced a collaboration with ASML (ASML) to develop advanced lithography processes for Xanadu's photonic quantum hardware.&nbsp;<a href="https://stocktwits.com/symbol/XNDU">XNDU stock</a> rose 1.7% in pre-market trading and was among the top-trending tickers on Stocktwits. Meanwhile,&nbsp;<a href="https://stocktwits.com/symbol/ASML">ASML stock</a> fell as much as 2.7% amid&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sp-500-targets-rise-barclays-hsbc-tom-lee-ai-earnings-bullish-chorus/cZt7GKzRJzc">broader market weakness</a>.&nbsp;Platform data showed retail sentiment around XNDU remained in ‘neutral’ territory over the past day, and chatter rose to ‘normal’ from ‘low’ levels, while sentiment around ASML trended in ‘bullish’ territory and chatter increased to ‘high’ from ‘normal’ levels.<h2 class="st-heading-2">Xanadu, ASML Target Optical Loss In Quantum Chips</h2>Xanadu said the collaboration focuses on reducing optical loss in the company’s photonic quantum computing chips. Unlike quantum systems built around trapped ions or superconducting circuits, including those developed by IonQ (IONQ) and IBM (IBM), Xanadu uses particles of light, or photons, to perform computations.A key manufacturing challenge for photonic chips is optical loss, which can weaken the signals carrying information through the device. Xanadu said that loss can be influenced by line-edge roughness, a measure of how smooth or jagged the microscopic waveguides etched into a chip are."Fault tolerance and error correction are arguably the most important technical objectives for the quantum computing industry," said Christian Weedbrook, Xanadu’s founder and CEO.<h2 class="st-heading-2">Xanadu Expands Quantum Manufacturing Efforts</h2>The ASML collaboration adds to Xanadu's broader push to develop the manufacturing infrastructure needed to scale its photonic quantum systems.Earlier this year, Xanadu partnered with EV Group on heterogeneous integration and wafer-bonding processes to move its chip designs toward high-volume manufacturing. The company also has a separate collaboration with Mitsubishi Chemical focused on applying quantum algorithms to semiconductor fabrication.Last month, Xanadu said it plans to establish a dedicated research, development and manufacturing facility in Toronto called Inception as part of Project OPTIMISM.&nbsp;Xanadu is targeting more than 1,000 logical qubits by 2031, according to a roadmap unveiled in August. Logical qubits are error-corrected qubits designed to be more reliable than the physical qubits that make up a quantum processor.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-ultra-luxury-foldable-i-phone-aims-past-samsung-says-analyst/cZt7RsIRJzP">Apple’s Foldable iPhone Could Become The ‘Birkin Of Smartphones’ In China, Analyst Says – But Others Think The Odds Are 4 To 1 Against The Company</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASML Holding NV

First Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund

iShares Semiconductor ETF

Yes, still bullish

No, losing confidence

Waiting to see earnings first

Never was bullish

Quantum computing stocks - like $IONQ, $RGTI, and $QBTS - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Stocktwits

IonQ Inc

Rigetti Computing Inc

D-Wave Quantum Inc

 - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Current Price	$2.88
Prev Close	$2.67
Open	$2.71
Dividend Yield	0.00%
50-Day Moving Average	$5.34
Beta	3.34
Avg. Volume	6.78M
PE Ratio	-7.77

52-Week High	$42.44
52-Week Low	$2.34
Market Capitalization	$812.73M
EPS (Annual)	$0.1196
Price to Book	2.59
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

XNDU Fundamentals